The management of biosafety risk in clinical laboratory of hospital during the outbreak of COVID-19 / 中华检验医学杂志
Chinese Journal of Laboratory Medicine
;
(12): 511-514, 2020.
Article
Dans Chinois
| WPRIM
| ID: wpr-871930
ABSTRACT
During the outbreak of COVID-19, the clinical laboratories of hospitals designated for the disease treatment are undertaking a lot of clinical testing work of infectious specimens. How to manage the biosafety risk is a major problem that the clinical laboratories and the departments of nosocomial infection control are facing. This article introduces the hierarchical prevention and control of biosafety risk from the perspective of the laboratory, with a view to provide reasonable and feasible methods for the clinical laboratories of hospitals at various levels during the outbreak.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Type d'étude:
Etude d'étiologie
langue:
Chinois
Texte intégral:
Chinese Journal of Laboratory Medicine
Année:
2020
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS